4//SEC Filing
Kapadia Sandip 4
Accession 0001677141-25-000008
CIK 0001802665other
Filed
Dec 8, 7:00 PM ET
Accepted
Dec 9, 4:10 PM ET
Size
9.2 KB
Accession
0001677141-25-000008
Insider Transaction Report
Form 4
Kapadia Sandip
CHIEF FINANCIAL OFFICER
Transactions
- Exercise/Conversion
Common Stock
2025-12-05$29.03/sh+20,000$580,600→ 20,000 total - Sale
Common Stock
2025-12-05$39.54/sh−20,000$790,896→ 0 total - Exercise/Conversion
Stock Option
2025-12-05−20,000→ 185,000 totalExercise: $29.03Exp: 2031-03-29→ Common Stock (20,000 underlying)
Footnotes (3)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.50 to $39.63. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The stock option shall vest with respect to 50% of the underlying shares on March 23, 2023 and with respect to the remaining shares, in twenty-four equal monthly installments beginning on April 23, 2023.
Documents
Issuer
Harmony Biosciences Holdings, Inc.
CIK 0001802665
Entity typeother
Related Parties
1- filerCIK 0001677141
Filing Metadata
- Form type
- 4
- Filed
- Dec 8, 7:00 PM ET
- Accepted
- Dec 9, 4:10 PM ET
- Size
- 9.2 KB